Annual CFO:
$157.72M+$141.02M(+844.31%)Summary
- As of today, ACAD annual cash from operations is $157.72 million, with the most recent change of +$141.02 million (+844.31%) on December 31, 2024.
- During the last 3 years, ACAD annual cash from operations has risen by +$283.38 million (+225.51%).
- ACAD annual cash from operations is now at all-time high.
Performance
ACAD Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly CFO:
$63.96M+$43.63M(+214.70%)Summary
- As of today, ACAD quarterly cash from operations is $63.96 million, with the most recent change of +$43.63 million (+214.70%) on June 30, 2025.
- Over the past year, ACAD quarterly cash from operations has increased by +$38.94 million (+155.69%).
- ACAD quarterly cash from operations is now -25.10% below its all-time high of $85.39 million, reached on December 31, 2023.
Performance
ACAD Quarterly Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFO:
$187.91M+$38.94M(+26.14%)Summary
- As of today, ACAD TTM cash from operations is $187.91 million, with the most recent change of +$38.94 million (+26.14%) on June 30, 2025.
- Over the past year, ACAD TTM cash from operations has increased by +$107.38 million (+133.35%).
- ACAD TTM cash from operations is now -7.31% below its all-time high of $202.73 million, reached on September 30, 2024.
Performance
ACAD TTM Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
ACAD Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +844.3% | +155.7% | +133.3% |
| 3Y3 Years | +225.5% | +587.3% | +244.9% |
| 5Y5 Years | +204.4% | +273.4% | +235.8% |
ACAD Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +225.5% | -25.1% | +208.5% | -7.3% | +264.8% |
| 5Y | 5-Year | at high | +204.4% | -25.1% | +183.8% | -7.3% | +227.6% |
| All-Time | All-Time | at high | +172.4% | -25.1% | +183.8% | -7.3% | +174.8% |
ACAD Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $63.96M(+214.7%) | $187.91M(+26.1%) |
| Mar 2025 | - | $20.32M(-49.7%) | $148.96M(-5.6%) |
| Dec 2024 | $157.72M(+844.3%) | $40.38M(-36.2%) | $157.72M(-22.2%) |
| Sep 2024 | - | $63.25M(+152.9%) | $202.73M(+151.8%) |
| Jun 2024 | - | $25.01M(-14.0%) | $80.53M(+26.4%) |
| Mar 2024 | - | $29.08M(-65.9%) | $63.71M(+281.5%) |
| Dec 2023 | $16.70M(+114.6%) | $85.39M(+244.8%) | $16.70M(+118.0%) |
| Sep 2023 | - | -$58.95M(-818.9%) | -$92.54M(-169.7%) |
| Jun 2023 | - | $8.20M(+145.7%) | -$34.31M(+38.3%) |
| Mar 2023 | - | -$17.93M(+24.8%) | -$55.64M(+51.2%) |
| Dec 2022 | -$114.03M(+9.3%) | -$23.85M(-3181.2%) | -$114.03M(-0.6%) |
| Sep 2022 | - | -$727.00K(+94.5%) | -$113.30M(+12.6%) |
| Jun 2022 | - | -$13.13M(+82.8%) | -$129.64M(+8.6%) |
| Mar 2022 | - | -$76.33M(-230.1%) | -$141.84M(-12.9%) |
| Dec 2021 | -$125.66M(+7.7%) | -$23.12M(-35.5%) | -$125.66M(+3.4%) |
| Sep 2021 | - | -$17.06M(+32.6%) | -$130.03M(+4.2%) |
| Jun 2021 | - | -$25.33M(+57.9%) | -$135.76M(+7.8%) |
| Mar 2021 | - | -$60.15M(-118.8%) | -$147.31M(-8.2%) |
| Dec 2020 | -$136.17M(+9.9%) | -$27.49M(-20.6%) | -$136.17M(+1.6%) |
| Sep 2020 | - | -$22.79M(+38.2%) | -$138.38M(-2.9%) |
| Jun 2020 | - | -$36.88M(+24.7%) | -$134.44M(+1.1%) |
| Mar 2020 | - | -$49.00M(-65.0%) | -$135.96M(+10.0%) |
| Dec 2019 | -$151.13M(+9.8%) | -$29.71M(-57.6%) | -$151.13M(+5.8%) |
| Sep 2019 | - | -$18.85M(+50.9%) | -$160.50M(+12.7%) |
| Jun 2019 | - | -$38.40M(+40.2%) | -$183.93M(+1.3%) |
| Mar 2019 | - | -$64.17M(-64.2%) | -$186.41M(-11.3%) |
| Dec 2018 | -$167.47M(+23.1%) | -$39.08M(+7.6%) | -$167.47M(-5.8%) |
| Sep 2018 | - | -$42.28M(-3.4%) | -$158.29M(+9.2%) |
| Jun 2018 | - | -$40.88M(+9.6%) | -$174.41M(+9.4%) |
| Mar 2018 | - | -$45.24M(-51.3%) | -$192.43M(+11.6%) |
| Dec 2017 | -$217.76M(-4.5%) | -$29.89M(+48.8%) | -$217.76M(+13.3%) |
| Sep 2017 | - | -$58.40M(+0.8%) | -$251.05M(-3.8%) |
| Jun 2017 | - | -$58.90M(+16.5%) | -$241.91M(-1.7%) |
| Mar 2017 | - | -$70.56M(-11.7%) | -$237.76M(-14.1%) |
| Dec 2016 | -$208.41M(-71.6%) | -$63.19M(-28.3%) | -$208.41M(-16.1%) |
| Sep 2016 | - | -$49.26M(+10.0%) | -$179.57M(-10.7%) |
| Jun 2016 | - | -$54.74M(-32.8%) | -$162.16M(-18.1%) |
| Mar 2016 | - | -$41.21M(-20.0%) | -$137.29M(-13.1%) |
| Dec 2015 | -$121.42M(-82.8%) | -$34.35M(-7.8%) | -$121.42M(-15.8%) |
| Sep 2015 | - | -$31.85M(-6.6%) | -$104.87M(-15.9%) |
| Jun 2015 | - | -$29.87M(-17.9%) | -$90.50M(-16.6%) |
| Mar 2015 | - | -$25.35M(-42.4%) | -$77.60M(-16.8%) |
| Dec 2014 | -$66.43M(-109.1%) | -$17.80M(-1.8%) | -$66.43M(-12.8%) |
| Sep 2014 | - | -$17.48M(-3.0%) | -$58.90M(-15.7%) |
| Jun 2014 | - | -$16.97M(-19.6%) | -$50.89M(-29.3%) |
| Mar 2014 | - | -$14.18M(-38.2%) | -$39.37M(-23.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2013 | -$31.77M(-46.9%) | -$10.27M(-8.3%) | -$31.77M(-14.3%) |
| Sep 2013 | - | -$9.47M(-74.0%) | -$27.80M(-17.6%) |
| Jun 2013 | - | -$5.44M(+17.3%) | -$23.63M(-2.8%) |
| Mar 2013 | - | -$6.58M(-4.6%) | -$22.99M(-6.3%) |
| Dec 2012 | -$21.63M(-8.7%) | -$6.30M(-18.7%) | -$21.63M(-4.6%) |
| Sep 2012 | - | -$5.31M(-10.5%) | -$20.67M(-5.8%) |
| Jun 2012 | - | -$4.80M(+8.2%) | -$19.54M(+2.4%) |
| Mar 2012 | - | -$5.23M(+2.0%) | -$20.02M(-0.6%) |
| Dec 2011 | -$19.90M(-85.9%) | -$5.34M(-27.9%) | -$19.90M(-99.9%) |
| Sep 2011 | - | -$4.17M(+21.0%) | -$9.96M(-19.9%) |
| Jun 2011 | - | -$5.28M(-3.4%) | -$8.30M(+11.3%) |
| Mar 2011 | - | -$5.11M(-210.9%) | -$9.36M(+12.6%) |
| Dec 2010 | -$10.70M(+22.0%) | $4.60M(+282.6%) | -$10.70M(+55.6%) |
| Sep 2010 | - | -$2.52M(+60.2%) | -$24.08M(+27.5%) |
| Jun 2010 | - | -$6.33M(+1.8%) | -$33.22M(-382.1%) |
| Mar 2010 | - | -$6.45M(+26.5%) | -$6.89M(+49.8%) |
| Dec 2009 | -$13.73M(+78.8%) | -$8.77M(+24.8%) | -$13.73M(+20.3%) |
| Sep 2009 | - | -$11.66M(-158.3%) | -$17.23M(+19.5%) |
| Jun 2009 | - | $20.00M(+250.5%) | -$21.41M(+62.8%) |
| Mar 2009 | - | -$13.29M(-8.3%) | -$57.61M(+11.2%) |
| Dec 2008 | -$64.87M(-18.1%) | -$12.27M(+22.5%) | -$64.87M(+2.4%) |
| Sep 2008 | - | -$15.84M(+2.2%) | -$66.47M(-4.2%) |
| Jun 2008 | - | -$16.21M(+21.1%) | -$63.76M(-4.1%) |
| Mar 2008 | - | -$20.55M(-48.2%) | -$61.25M(-11.5%) |
| Dec 2007 | -$54.93M(-32.6%) | -$13.87M(-5.5%) | -$54.93M(-2.5%) |
| Sep 2007 | - | -$13.14M(+4.0%) | -$53.60M(-2.0%) |
| Jun 2007 | - | -$13.69M(+3.7%) | -$52.56M(-10.3%) |
| Mar 2007 | - | -$14.22M(-13.4%) | -$47.68M(-15.1%) |
| Dec 2006 | -$41.42M(-104.4%) | -$12.54M(-3.6%) | -$41.42M(-15.3%) |
| Sep 2006 | - | -$12.11M(-37.5%) | -$35.91M(-19.4%) |
| Jun 2006 | - | -$8.80M(-10.5%) | -$30.07M(-7.5%) |
| Mar 2006 | - | -$7.96M(-13.2%) | -$27.96M(-38.0%) |
| Dec 2005 | -$20.26M(+2.1%) | -$7.03M(-12.3%) | -$20.26M(-53.2%) |
| Sep 2005 | - | -$6.26M(+6.5%) | -$13.23M(-90.0%) |
| Jun 2005 | - | -$6.70M(-2400.7%) | -$6.96M(-34.8%) |
| Mar 2005 | - | -$267.80K(+94.5%) | -$5.17M(+65.3%) |
| Dec 2004 | -$20.69M(-110.8%) | - | - |
| Jun 2004 | - | -$4.90M(-25.6%) | -$14.90M(-22.0%) |
| Mar 2004 | - | -$3.90M(-19.1%) | -$12.21M(-24.4%) |
| Dec 2003 | -$9.82M(-6.2%) | -$3.28M(-16.2%) | -$9.82M(-50.1%) |
| Sep 2003 | - | -$2.82M(-27.6%) | -$6.54M(-75.7%) |
| Jun 2003 | - | -$2.21M(-46.0%) | -$3.72M(-146.0%) |
| Mar 2003 | - | -$1.51M | -$1.51M |
| Dec 2002 | -$9.24M(+18.2%) | - | - |
| Dec 2001 | -$11.29M(-144.6%) | - | - |
| Dec 2000 | $25.33M | - | - |
FAQ
- What is ACADIA Pharmaceuticals Inc. annual cash from operations?
- What is the all-time high annual cash from operations for ACADIA Pharmaceuticals Inc.?
- What is ACADIA Pharmaceuticals Inc. annual cash from operations year-on-year change?
- What is ACADIA Pharmaceuticals Inc. quarterly cash from operations?
- What is the all-time high quarterly cash from operations for ACADIA Pharmaceuticals Inc.?
- What is ACADIA Pharmaceuticals Inc. quarterly cash from operations year-on-year change?
- What is ACADIA Pharmaceuticals Inc. TTM cash from operations?
- What is the all-time high TTM cash from operations for ACADIA Pharmaceuticals Inc.?
- What is ACADIA Pharmaceuticals Inc. TTM cash from operations year-on-year change?
What is ACADIA Pharmaceuticals Inc. annual cash from operations?
The current annual cash from operations of ACAD is $157.72M
What is the all-time high annual cash from operations for ACADIA Pharmaceuticals Inc.?
ACADIA Pharmaceuticals Inc. all-time high annual cash from operations is $157.72M
What is ACADIA Pharmaceuticals Inc. annual cash from operations year-on-year change?
Over the past year, ACAD annual cash from operations has changed by +$141.02M (+844.31%)
What is ACADIA Pharmaceuticals Inc. quarterly cash from operations?
The current quarterly cash from operations of ACAD is $63.96M
What is the all-time high quarterly cash from operations for ACADIA Pharmaceuticals Inc.?
ACADIA Pharmaceuticals Inc. all-time high quarterly cash from operations is $85.39M
What is ACADIA Pharmaceuticals Inc. quarterly cash from operations year-on-year change?
Over the past year, ACAD quarterly cash from operations has changed by +$38.94M (+155.69%)
What is ACADIA Pharmaceuticals Inc. TTM cash from operations?
The current TTM cash from operations of ACAD is $187.91M
What is the all-time high TTM cash from operations for ACADIA Pharmaceuticals Inc.?
ACADIA Pharmaceuticals Inc. all-time high TTM cash from operations is $202.73M
What is ACADIA Pharmaceuticals Inc. TTM cash from operations year-on-year change?
Over the past year, ACAD TTM cash from operations has changed by +$107.38M (+133.35%)